Perfenidone in Type 2 Diabetic Patients With Diabetic Neuropathy

Clinical trial NCT06224790 · COMPLETED

Trial details

NCT number: NCT06224790
Sponsor: Sidrah Lodhi
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetic Nephropathies Type 2 Diabetes

Start date: 2024-03-10
Primary completion: 2025-03-07
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.